Olympus Scope Problems Lead to FDA Import Warning

Agency is blocking several Olympus medical scopes from entering the U.S., claiming they have repeatedly been the focus of quality control problems.

Federal health regulators have warned doctors nationwide that ongoing quality control problems involving Olympus Medical endoscopes and duodenoscopes manufactured in Japan may pose safety risks to patients, including the potential spread of dangerous infections.

The U.S. Food and Drug Administration (FDA) issued an Olympus medical scope import alert in a letter to healthcare providers on October 20. The agency indicates that it is seeking to prevent future shipments of certain Olympus Medical Systems Corporation devices from entering the United States and that doctors should be aware that the company’s products may be dangerous.

Olympus Endoscope Risks

Best known for its cameras and photography equipment, Olympus is also a leading manufacturer of endoscopes, which are medical devices equipped with cameras and lights that allow doctors to examine and treat internal organs without open surgery. These products are commonly used during procedures such as endoscopic retrograde cholangiopancreatography (ERCP), colonoscopies, upper endoscopies and bronchoscopies.

During these examinations, endoscopes come into contact with blood, tissue, bodily fluids and potentially infectious material. Because the devices are reused on multiple patients, they must undergo thorough cleaning and disinfection or sterilization between uses, which is known as “reprocessing.”

However, the FDA has repeatedly warned that narrow internal channels and other complex design features can make endoscopes difficult to clean and disinfect properly. As a result, infectious material may remain trapped inside the devices, potentially allowing dangerous bacteria and other pathogens to spread between patients.

The agency has spent years urging manufacturers to address these risks through improved reprocessing instructions and disposable components. These include removable or disposable parts designed to make difficult-to-clean areas, such as the elevator mechanism in duodenoscopes, easier to disinfect.

Despite these efforts, the FDA continues to raise concerns about endoscope infection risks. A number of former patients have also filed Olympus scope lawsuits, alleging the manufacturer failed to adequately address design defects that allowed dangerous infections to spread, sometimes resulting in fatal complications.

Olympus Endoscope Alert

The FDA’s import alert is intended to prevent future shipments of certain Olympus medical devices manufactured in Japan from entering the United States, including:

• Ureterorenoscopes
• Bronchoscopes
• Laparoscopes
• Automated endoscope reprocessors
• Ingestible telemetric gastrointestinal capsule imaging systems
• Enteroscopes

According to the FDA, Olympus has failed to adequately address longstanding regulatory compliance and quality control problems, prompting the agency to restrict imports of the affected devices.

“Be aware of the FDA import Alert for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus), under which the devices will be refused entry into the United States.”

— U.S. Food and Drug Administration Letter to Healthcare Professionals

The FDA is urging healthcare providers to review Import Alert 89-04 and familiarize themselves with the model numbers and Unique Device Identifiers (UDIs) of the affected products. However, the agency emphasized that the restrictions do not extend to accessories or other related products used with the devices covered by the alert.

The import restrictions also do not require healthcare providers to stop using Olympus devices already in service, provided they are functioning properly. However, the FDA stresses the importance of following all manufacturer instructions for cleaning, disinfecting and reprocessing the equipment to reduce the risk of complications.

Healthcare providers are also advised to avoid using damaged devices or those that fail leak testing, and to maintain routine inspection and maintenance schedules consistent with manufacturer recommendations.

A complete list of affected devices is available in the FDA’s letter to healthcare professionals. The agency also encourages doctors and patients to report any problems involving Olympus medical devices through its MedWatch adverse event reporting system.

Olympus Medical Scope Lawsuits

The warning comes as the manufacturer faces an increasing number of Olympus medical scope lawsuits filed by patients who suffered serious infections following procedures involving the company’s medical devices. The lawsuits claim that the manufacturer failed to correctly design products to be safe and effective, and has refused to properly address the problem for years.

Medical scope infection lawyers continue to investigate potential claims against Olympus, Fujifilm and other manufacturers on behalf of those nationwide who experienced complications following an endoscopic procedure, including:

Potential contaminated scope infection lawsuits are reviewed and pursued on a contingency fee basis, meaning there are no upfront expenses for a legal evaluation. Attorneys receive payment only if compensation is recovered through a settlement or other successful resolution.

Sign up for more legal news that could affect you or your family.